BNR - Burning Rock Biotech GAAP EPS of -$0.31 beats by $0.03 revenue of $21.74M misses by $0.32M
- Burning Rock Biotech press release ( NASDAQ: BNR ): Q3 GAAP EPS of -$0.31 beats by $0.03 .
- Revenue of $21.74M (+22.1% Y/Y) misses by $0.32M .
- Non-GAAP gross margin was 75.7% for the three months ended September 30, 2022, compared to 73.4% for the same period in 2021.
- "We therefore revise our 2022 full-year revenue guidance to a growth of ~5% compared to 2021 vs. estimated growth of 6.9% Y/Y."
For further details see:
Burning Rock Biotech GAAP EPS of -$0.31 beats by $0.03, revenue of $21.74M misses by $0.32M